Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma

被引：0
|
作者：
Kumar, Sakthi
Talabi, Toluwalase
Mahmoudieh, Mahta
Pennington, Daniel
Saboda, Kathylynn
Arshad, Junaid
Scott, Aaron James
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Coll Med Tucson, Tucson, AZ USA
[3] Univ Arizona, Dept Neurosci, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14619
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EXTRAPULMONARY POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMAS (PDNEC) TREATED WITH CISPLATIN PLUS IRINOTECAN
    de Celis Ferrari, Anezka Rubin
    Braghiroli, Maria Ignez
    Bariani, Giovanni Mendonca
    Munhoz, Rodrigo Ranella
    Pfiffer, Tulio Eduardo
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    ANNALS OF ONCOLOGY, 2011, 22 : v80 - v80
  • [32] RETROSPECTIVE ANALYSIS OF AMRUBICIN IN PATIENTS WITH GASTROINTESTINAL POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA (GI-PDNEC) REFRACTORY TO CHEMOTHERAPY
    Nishitani, H.
    Hamaguchi, T.
    Ikeda, H.
    Iwasa, S.
    Okita, N.
    Nakajima, T. E.
    Kato, K.
    Yamada, Y.
    Hashimoto, H.
    Shimada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 268 - 268
  • [33] Comparative Efficacy of 2nd-Line Chemotherapy Regimens in Extrapulmonary Poorly-Differentiated Neuroendocrine Carcinoma (PD NEC): The Mayo Clinic Experience
    McGarrah, P.
    Leventakos, K.
    Hobday, T.
    Molina, J.
    Finnes, H.
    Westin, G.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2019, 108 : 155 - 155
  • [34] IMMUNO-CHEMOTHERAPY IN PATIENTS WITH INOPERABLE MALIGNANT-MELANOMA
    KOKOSCHKA, EM
    MICKSCHE, M
    LUGER, T
    WIENER KLINISCHE WOCHENSCHRIFT, 1978, 90 (04) : 145 - 145
  • [35] Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology Well Differentiated Versus Poorly Differentiated
    Raj, Nitya
    Valentino, Emily
    Capanu, Marinela
    Tang, Laura H.
    Basturk, Olca
    Untch, Brian R.
    Allen, Peter J.
    Klimstra, David S.
    Reidy-Lagunes, Diane
    PANCREAS, 2017, 46 (03) : 296 - 301
  • [36] Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma
    Okita, Natsuko Tsuda
    Kato, Ken
    Takahari, Daisuke
    Hirashima, Yoshinori
    Nakajima, Takako E.
    Matsubara, Junichi
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Taniguchi, Hirokazu
    Shirao, Kuniaki
    GASTRIC CANCER, 2011, 14 (02) : 161 - 165
  • [37] Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma
    Natsuko Tsuda Okita
    Ken Kato
    Daisuke Takahari
    Yoshinori Hirashima
    Takako E. Nakajima
    Junichi Matsubara
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Hirokazu Taniguchi
    Kuniaki Shirao
    Gastric Cancer, 2011, 14 : 161 - 165
  • [38] Poorly differentiated neuroendocrine carcinoma of the larynx Diagnostic features, treatment strategy, and prognosis
    Jumah, M. D.
    Fleiner, F.
    Wendt, S.
    Pavel, M.
    Schwabe, M.
    Goektas, Oe.
    HNO, 2009, 57 (02) : 135 - 141
  • [39] The pitfalls in cytology diagnosis of poorly differentiated neuroendocrine carcinoma of lung and their treatment response
    Saha, Debarshi
    Kumar, Ankit
    Banerjee, Sourjya
    Nirupama, M.
    Sridevi, H. B.
    Garg, Priya
    Lobo, Flora D.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 213 - 217
  • [40] Advances in the treatment of gastroenteropancreatic poorly differentiated neuroendocrine carcinoma at our hospital.
    Nishina, Shinichi
    Yokota, Mitsuru
    Nagahisa, Yoshio
    Kawata, Kenji
    Okabe, Michio
    Masui, Toshihiko
    Kawamoto, Kazuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 595 - 595
12345